[Puberty and adult height in congenital virilizing adrenal hyperplasia (author's transl)].
A study of 52 pubertal patients having been treated for virilizing adrenal hyperplasia (38 females and 14 males) leads to emphasize the importance of the precocity and accuracy of treatment. In patients with delayed treatment, mainly when they are girls, an advanced or true precocious puberty will increase the advance of bone age and reduce adult height. But, whatever be the time of onset of treatment and of pubertal achievement, no important or sustained sexual improvement was found in patients receiving a well-controlled treatment.
D000293:Adolescent; D000312:Adrenal Hyperplasia, Congenital / Q000503:physiopathology* / Q000628:therapy; D000328:Adult; D001827:Body Height; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D011627:Puberty; D013997:Time Factors
La puberté et la taille adulte dans l'hyperplasie congénitale virilisante des surrénales.